P/B
2,1
Mirion Technologies
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
$3.8B
Market Cap • 9/18/2026
2018
(8 years)
Founded
2020
(6 years ago)
IPO
NYSE
Listing Exchange
United States
Country
Valuation
P/S
3,7
P/EBITDA
18,7
P/OCF
22,2
P/FCF
28,7
P/E
157,6
BVPS
6,8
EPS
0,1
Market Cap
Market Cap
3,8B
EV
4,7B
EV/Revenue
4,6
EV/EBITDA
23
EV/EBIT
86,2
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-9,9%
Total Yield
-9,9%
Payout
0%
Retained Earnings
-508,4M
Profitability
Gross Margin
48%
EBITDA Margin
20%
EBIT Margin
5,3%
Net Margin
2,5%
D&A/EBITDA
0%
R&D/Revenue
3,9%
Capex/Revenue
3,8%
Capex/D&A
26%
Capex/OCF
22,6%
SBC/OCF
11,4%
% PPE
5,2%
% Goodwill
52,9%
ROE
1,5%
ROIC
1,8%
Growth
CAGR Op. Income 5Y
149,2%
CAGR Net Income 5Y
7,1%
Leverage
N.D./EBITDA
4
Debt/Equity
0%
Current Ratio
3,2
Quick Ratio
2,4
Interest Coverage
157,1%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!